Exelixis
EXEL
#1709
Rank
NZ$20.71 B
Marketcap
NZ$76.94
Share price
4.06%
Change (1 day)
30.61%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company